ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Division Spotlight
Accelerator Applications
The division was organized to promote the advancement of knowledge of the use of particle accelerator technologies for nuclear and other applications. It focuses on production of neutrons and other particles, utilization of these particles for scientific or industrial purposes, such as the production or destruction of radionuclides significant to energy, medicine, defense or other endeavors, as well as imaging and diagnostics.
Meeting Spotlight
2024 ANS Annual Conference
June 16–19, 2024
Las Vegas, NV|Mandalay Bay Resort and Casino
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Apr 2024
Jan 2024
Latest Journal Issues
Nuclear Science and Engineering
May 2024
Nuclear Technology
Fusion Science and Technology
Latest News
Framatome signs contracts with Sizewell C
French nuclear developer Framatome is slated to deliver key equipment for Sizewell C Ltd.’s two large reactors planned for the United Kingdom’s Suffolk coast.
The agreement, reportedly worth multiple billions of euros, was announced this week and will involve Framatome from the design phase until commissioning. The company also agreed to a long-term fuel supply deal. Framatome is 80.5 percent owned by France’s EDF and 19.5 percent owned by Mitsubishi Heavy Industries.
The American Nuclear Society provides statements which reflect the Society's perspectives on issues of public interest that involve various aspects of nuclear science and technology. Position statements are prepared by key members whose relevant experience or publications inform the documents and then the documents are reviewed by ANS committees and divisions. The final position statements are approved by the Board of Directors.
Advanced Reactors — ANS-35-2022
Read the Statement
Assuring U.S. Global Nuclear Leadership — ANS-83-2021
Clearance of Solid Materials from Nuclear Facilities — ANS-50-2023
Creation of an Independent Entity to Manage U.S. Used Nuclear Fuel — ANS-22-2015
Decommissioning of Nuclear Power Reactors — ANS-13-2015
Disposal of Low-Level Radioactive Waste — ANS-11-2017
More:Background Information
Disposition of Surplus Weapons Plutonium — ANS-47-2020
Diversity in the Nuclear Profession — ANS-66-2018
Domestic Production of Stable and Radioactive Isotopes — ANS-30-2022
Education, Training, and Workforce Development for Nuclear Science, Engineering, and Technology — ANS-85-2022
Fusion Energy — ANS-12-2016
Health Effects of Low-Level Radiation — ANS-41-2020
Interim Storage of Used or Spent Nuclear Fuel — ANS-76-2017
Licensing of Yucca Mountain as a Geological Repository for Radioactive Wastes — ANS-80-2017
Management of the Nation's Used Nuclear Fuel and High-Level Waste — ANS-3-2023
Nonproliferation — ANS-55-2023
Nuclear Energy's Role in Climate Change Policy — ANS-44-2022
More:Platform
Nuclear Engineering Licensure — ANS-61-2016
Nuclear Fuel Recycling — ANS-45-2014
The Nuclear Regulatory Commission — ANS-77-2022
Nuclear Technology's Critical Role In The World's Future Energy Supply — ANS-43-2019
Price-Anderson Act — ANS-54-2023
Risk-Informed and Performance-Based Regulations for Nuclear Power Plants — ANS-46-2017
Safeguards and Security for Advanced Reactors Using HALEU — ANS-84-2023
Safety of Nuclear Power — ANS-51-2021
Small Modular Reactors — ANS-25-2020
Space Nuclear Power and Propulsion Systems — ANS-40-2009
Transportation of Radioactive Materials — ANS-18-2021
More:Backgrounder
U.S. Commercial Nuclear Power Plants: A Vital National Asset — ANS-26-2017
The Use of Highly Enriched Uranium for the Production of Medical Isotopes — ANS-72-2022
The Use of Thorium as Nuclear Fuel — ANS-78-2020